Freestone Capital Holdings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.9M | Sell |
27,406
-231
| -0.8% | -$236K | 0.85% | 22 |
|
|
2026
Q1 | $25.4M | Sell |
27,637
-902
| -3% | -$914K | 0.77% | 22 |
|
|
2025
Q4 | $30.7M | Buy |
28,539
+1,384
| +5% | +$1.32M | 0.91% | 19 |
|
|
2025
Q3 | $20.7M | Sell |
27,155
-271
| -1% | -$202K | 0.63% | 27 |
|
|
2025
Q2 | $21.4M | Buy |
27,426
+1,318
| +5% | +$1.02M | 0.72% | 22 |
|
|
2025
Q1 | $21.6M | Sell |
26,108
-1,501
| -5% | -$1.25M | 0.8% | 20 |
|
|
2024
Q4 | $21.3M | Buy |
27,609
+855
| +3% | +$708K | 0.74% | 22 |
|
|
2024
Q3 | $23.7M | Buy |
26,754
+189
| +0.7% | +$170K | 0.81% | 19 |
|
|
2024
Q2 | $24.1M | Buy |
26,565
+227
| +0.9% | +$182K | 0.86% | 18 |
|
|
2024
Q1 | $20.5M | Buy |
26,338
+1,531
| +6% | +$1.09M | 0.76% | 20 |
|
|
2023
Q4 | $14.5M | Buy |
24,807
+439
| +2% | +$256K | 0.65% | 28 |
|
|
2023
Q3 | $13.1M | Sell |
24,368
-321
| -1% | -$165K | 0.69% | 27 |
|
|
2023
Q2 | $11.6M | Buy |
24,689
+783
| +3% | +$328K | 0.47% | 39 |
|
|
2023
Q1 | $8.21M | Sell |
23,906
-2,130
| -8% | -$718K | 0.36% | 48 |
|
|
2022
Q4 | $9.52M | Sell |
26,036
-1,205
| -4% | -$427K | 0.44% | 43 |
|
|
2022
Q3 | $8.81M | Sell |
27,241
-4,857
| -15% | -$1.54M | 0.4% | 38 |
|
|
2022
Q2 | $10.4M | Sell |
32,098
-3,075
| -9% | -$923K | 0.4% | 39 |
|
|
2022
Q1 | $10.1M | Buy |
35,173
+588
| +2% | +$151K | 0.4% | 54 |
|
|
2021
Q4 | $9.55M | Buy |
34,585
+1,360
| +4% | +$345K | 0.4% | 51 |
|
|
2021
Q3 | $7.68M | Sell |
33,225
-25
| -0.1% | -$6.17K | 0.39% | 59 |
|
|
2021
Q2 | $7.63M | Buy |
33,250
+7,427
| +29% | +$1.49M | 0.38% | 63 |
|
|
2021
Q1 | $4.82M | Buy |
25,823
+196
| +0.8% | +$38.3K | 0.26% | 93 |
|
|
2020
Q4 | $4.33M | Sell |
25,627
-22,797
| -47% | -$3.4M | 0.25% | 89 |
|
|
2020
Q3 | $7.17M | Sell |
48,424
-729
| -1% | -$113K | 0.47% | 50 |
|
|
2020
Q2 | $8.07K | Buy |
49,153
+27,480
| +127% | +$4.22M | 0.09% | 45 |
|
|
2020
Q1 | $3.01K | Sell |
21,673
-1,241
| -5% | -$171K | 0.07% | 107 |
|
|
2019
Q4 | $3.01K | Buy |
22,914
+550
| +2% | +$63.8K | 0.06% | 137 |
|
|
2019
Q3 | $2.5K | Sell |
22,364
-12
| -0.1% | -$1.34K | 0.06% | 156 |
|
|
2019
Q2 | $2.48K | Buy |
22,376
+1,105
| +5% | +$130K | 0.06% | 144 |
|
|
2019
Q1 | $2.76M | Sell |
21,271
-2,089
| -9% | -$254K | 0.16% | 144 |
|
|
2018
Q4 | $2.7M | Sell |
23,360
-2,537
| -10% | -$283K | 0.18% | 135 |
|
|
2018
Q3 | $2.78M | Sell |
25,897
-1,686
| -6% | -$169K | 0.02% | 150 |
|
|
2018
Q2 | $2.35M | Buy |
27,583
+267
| +1% | +$21.9K | 0.01% | 153 |
|
|
2018
Q1 | $2.11M | Buy |
27,316
+901
| +3% | +$72.5K | 0.12% | 147 |
|
|
2017
Q4 | $2.23M | Buy |
26,415
+618
| +2% | +$52.6K | 0.15% | 143 |
|
|
2017
Q3 | $2.21M | Buy |
25,797
+262
| +1% | +$21.5K | 0.16% | 135 |
|
|
2017
Q2 | $2.1M | Buy |
25,535
+339
| +1% | +$27.7K | 0.16% | 136 |
|
|
2017
Q1 | $2.12M | Buy |
25,196
+1,404
| +6% | +$112K | 0.16% | 140 |
|
|
2016
Q4 | $1.75M | Buy |
23,792
+1,272
| +6% | +$94.7K | 0.15% | 140 |
|
|
2016
Q3 | $1.81M | Sell |
22,520
-2,127
| -9% | -$170K | 0.17% | 131 |
|
|
2016
Q2 | $1.94M | Buy |
24,647
+346
| +1% | +$26K | 0.19% | 119 |
|
|
2016
Q1 | $1.75M | Sell |
24,301
-3,293
| -12% | -$249K | 0.18% | 107 |
|
|
2015
Q4 | $2.33M | Buy |
27,594
+2,099
| +8% | +$174K | 0.24% | 67 |
|
|
2015
Q3 | $2.13M | Buy |
+25,495
| New | +$2.15M | 0.23% | 67 |
|
|
2013
Q3 | – | Sell |
-8,713
| Closed | -$428K | – | 384 |
|
|
2013
Q2 | $428K | Buy |
+8,713
| New | +$474K | 0.09% | 211 |
|
Other funds holding LLY
Freestone Capital Holdings's LLY Position: Q2 2026 in Review
Freestone Capital Holdings reduced its Eli Lilly (LLY) stake by 0.84% in Q2 2026, selling an estimated $236K and leaving 27,406 shares worth $32.9M. The position accounts for 0.85% of the portfolio, ranked #22.
Freestone Capital Holdings first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Freestone Capital Holdings held 27,406 shares of Eli Lilly worth $32.9M as of Q2 2026.
- Freestone Capital Holdings sold 231 Eli Lilly shares in Q2 2026, an estimated $236K.
- Eli Lilly made up 0.85% of Freestone Capital Holdings's portfolio in Q2 2026, its #22 holding.
- Freestone Capital Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.